Literature DB >> 13974350

The treatment of sleeping sickness (mainly due to Trypanosoma rhodesiense) with melarsoprol. I. Reactions observed during treatment.

D H ROBERTSON.   

Abstract

Entities:  

Keywords:  ARSENICALS; DIMERCAPROL; TRYPANOSOMIASIS, AFRICAN

Mesh：

Substances：

Year:  1963        PMID： 13974350     DOI： 10.1016/0035-9203(63)90026-9

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN： 0035-9203            Impact factor:   2.184


× No keyword cloud information.
  4 in total

1.  The six diseases WHO. Human trypanosomiasis in Africa.

Authors:  J R Foulkes
Journal:  Br Med J (Clin Res Ed)       Date:  1981-10-31

Review 2.  Human African trypanosomiasis: pharmacological re-engagement with a neglected disease.

Authors:  M P Barrett; D W Boykin; R Brun; R R Tidwell
Journal:  Br J Pharmacol       Date:  2007-07-09       Impact factor: 8.739

3.  The epidemiology of human sleeping sickness in the Lambwe Valley, South Nyanza, Kenya.

Authors:  H J Watson
Journal:  Bull World Health Organ       Date:  1972       Impact factor: 9.408

4.  Safety and efficacy of the 10-day melarsoprol schedule for the treatment of second stage Rhodesiense sleeping sickness.

Authors:  Irene Kuepfer; Caecilia Schmid; Mpairwe Allan; Andrew Edielu; Emma P Haary; Abbas Kakembo; Stafford Kibona; Johannes Blum; Christian Burri
Journal:  PLoS Negl Trop Dis       Date:  2012-08-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.